$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000162828018012594 Filed on October 17, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$3.730M	$3.667M	$3.547M
YoY Change	-24.34%	3.39%	4.64%
Cost Of Revenue	$1.980M	$1.821M	$2.041M
YoY Change	-30.77%	-10.77%	0.45%
Gross Profit	$1.750M	$1.846M	$1.506M
YoY Change	-15.46%	22.58%	10.91%
Gross Profit Margin	46.92%	50.33%	42.45%
Selling, General & Admin	$3.510M	$3.350M	$4.178M
YoY Change	-13.97%	-19.82%	1.28%
% of Gross Profit	200.57%	181.5%	277.48%
Research & Development	$1.060M	$1.178M	$840.6K
YoY Change	20.45%	40.2%	-30.11%
% of Gross Profit	60.57%	63.85%	55.83%
Depreciation & Amortization	$0.00	$30.00K	$70.00K
YoY Change	-100.0%	-57.14%	0.0%
% of Gross Profit	0.0%	1.63%	4.65%
Operating Expenses	$4.570M	$4.528M	$5.019M
YoY Change	-7.68%	-9.77%	-5.8%
Operating Profit	-$2.820M	-$2.683M	-$3.513M
YoY Change	-2.08%	-23.63%	-11.52%
Interest Expense			$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	$20.00K	$20.00K
YoY Change
Pretax Income	-$2.800M	$1.090M	-$3.510M
YoY Change	-2.78%	-131.05%	-10.23%
Income Tax
% Of Pretax Income
Net Earnings	-$2.800M	$1.086M	-$3.509M
YoY Change	-2.78%	-130.95%	-10.21%
Net Earnings / Revenue	-75.07%	29.62%	-98.94%
Basic Earnings Per Share		$0.15	-$3.11
Diluted Earnings Per Share	-$3.784M	$0.08	-$3.11
COMMON SHARES
Basic Shares Outstanding	7.365M shares	7.365M shares	2.036M shares
Diluted Shares Outstanding		13.95M shares	2.036M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.780M	$7.530M	$3.970M
YoY Change	67.82%	89.67%	-47.56%
Cash & Equivalents	$6.780M	$7.531M	$3.969M
Short-Term Investments
Other Short-Term Assets	$860.0K	$830.0K	$2.040M
YoY Change	-67.42%	-59.31%	58.14%
Inventory	$2.862M	$2.597M	$1.786M
Prepaid Expenses
Receivables	$1.083M	$1.616M	$423.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.59M	$12.57M	$8.221M
YoY Change	27.27%	52.93%	-22.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$407.3K	$380.5K	$417.3K
YoY Change	-7.6%	-8.82%	-28.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$90.00K	$130.0K
YoY Change	-50.0%	-30.77%	-23.53%
Total Long-Term Assets	$2.406M	$466.7K	$552.0K
YoY Change	385.17%	-15.45%	-27.37%
TOTAL ASSETS
Total Short-Term Assets	$11.59M	$12.57M	$8.221M
Total Long-Term Assets	$2.406M	$466.7K	$552.0K
Total Assets	$13.99M	$13.04M	$8.773M
YoY Change	45.76%	48.62%	-22.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.298M	$1.151M	$725.2K
YoY Change	77.02%	58.74%	2.14%
Accrued Expenses	$1.659M	$1.921M	$1.911M
YoY Change	-29.76%	0.54%	5.58%
Deferred Revenue	$0.00
YoY Change	-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.593M	$4.179M	$4.255M
YoY Change	43.89%	-1.8%	18.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.300M		$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$1.300M	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.593M	$4.179M	$4.255M
Total Long-Term Liabilities	$1.300M	$0.00	$0.00
Total Liabilities	$7.894M	$4.179M	$4.255M
YoY Change	72.29%	-1.8%	16.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$191.0M	-$188.2M	-$188.5M
YoY Change	-0.17%	-0.16%
Common Stock	$74.00	$737.00	$215.00
YoY Change	-72.69%	242.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.098M	$8.860M	$4.518M
YoY Change
Total Liabilities & Shareholders Equity	$13.99M	$13.04M	$8.773M
YoY Change	45.76%	48.62%	-22.71%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$2.800M	$1.086M	-$3.509M
YoY Change	-2.78%	-130.95%	-10.21%
Depreciation, Depletion And Amortization	$0.00	$30.00K	$70.00K
YoY Change	-100.0%	-57.14%	0.0%
Cash From Operating Activities	-$720.0K	$380.0K	-$2.870M
YoY Change	-77.29%	-113.24%	-21.58%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	$20.00K	-$30.00K
YoY Change	-66.67%	-166.67%	0.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$30.00K	$20.00K	-$30.00K
YoY Change	-66.67%	-166.67%	0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	10.00K	3.260M
YoY Change	-99.7%	-99.69%	-4757.14%
NET CHANGE
Cash From Operating Activities	-720.0K	380.0K	-2.870M
Cash From Investing Activities	-30.00K	20.00K	-30.00K
Cash From Financing Activities	10.00K	10.00K	3.260M
Net Change In Cash	-740.0K	410.0K	360.0K
YoY Change	-1025.0%	13.89%	-109.57%
FREE CASH FLOW
Cash From Operating Activities	-$720.0K	$380.0K	-$2.870M
Capital Expenditures	-$30.00K	$20.00K	-$30.00K
Free Cash Flow	-$690.0K	$360.0K	-$2.840M
YoY Change	-77.6%	-112.68%	-21.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7365038	shares
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	NURO
CY2017Q4	nuro	Accrued Compensation AccruedCompensation	786184	USD
CY2018Q3	nuro	Accrued Compensation AccruedCompensation	578167	USD
CY2017Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	666375	USD
CY2018Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	1105960	USD
	nuro	Exchange Of Warrant Liability For Preferred Stock ExchangeOfWarrantLiabilityForPreferredStock	-40772	USD
	nuro	Exchange Of Warrant Liability For Preferred Stock ExchangeOfWarrantLiabilityForPreferredStock	0	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	244611	USD
	nuro	Fair Value Adjustmentof Warrants Repricing FairValueAdjustmentofWarrantsRepricing	0	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-30529	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-852596	USD
CY2018Q3	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	294264	USD
CY2017Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2018Q3	nuro	Technology Fees TechnologyFees	450000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	733305	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1151235	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1049329	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1615842	USD
CY2017Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	160800	USD
CY2018Q3	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	139900	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2362124	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1921406	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	603000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	285000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196355142	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197072928	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7728775	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7896343	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	933523	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	885541	shares
CY2017Q4	us-gaap	Assets Assets	9599224	USD
CY2018Q3	us-gaap	Assets Assets	13038326	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	9103374	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	12571603	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3949135	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3969218	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4043681	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7530598	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	20083	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3486917	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2706066	shares
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7365038	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2706066	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7365038	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	271	USD
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	737	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	2040997	USD
	us-gaap	Cost Of Revenue CostOfRevenue	7378001	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	1821111	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6726675	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	820031	USD
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	USD
	us-gaap	Depreciation Depreciation	198892	USD
	us-gaap	Depreciation Depreciation	166262	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.62
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.62
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	263734	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y0M23D
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-208480	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1258466	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3925595	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1015489	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3990266	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	1505683	USD
	us-gaap	Gross Profit GrossProfit	4784860	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	1845669	USD
	us-gaap	Gross Profit GrossProfit	5634663	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22074	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	417930	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-315285	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-786986	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	678326	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-146454	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	4528297	USD
	us-gaap	Operating Expenses OperatingExpenses	15105094	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	297558	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	533836	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	454779	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	365547	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-425242	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6584674	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6847164	shares
CY2017Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	3881	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	219498	USD
CY2018Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	18686	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	40965	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1637268	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	894815	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2142561	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	2597340	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	505293	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1702525	USD
CY2017Q4	us-gaap	Liabilities Liabilities	4581835	USD
CY2018Q3	us-gaap	Liabilities Liabilities	4178601	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9599224	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13038326	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4581835	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4178601	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-01-15
CY2018Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2018Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9569800	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9254	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70226	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105888	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9479491	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3583551	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-3508983	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9979179	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	1086058	USD
	us-gaap	Net Income Loss NetIncomeLoss	2826238	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6342081	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16853959	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1086058	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2826238	USD
CY2017Q3	us-gaap	Noninterest Income NoninterestIncome	0	USD
	us-gaap	Noninterest Income NoninterestIncome	0	USD
CY2018Q3	us-gaap	Noninterest Income NoninterestIncome	3750000	USD
	us-gaap	Noninterest Income NoninterestIncome	12255704	USD
	us-gaap	Operating Expenses OperatingExpenses	14983537	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	5018547	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	55008	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	440842	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	86255	USD
	us-gaap	Proceeds From Collaborators ProceedsFromCollaborators	12700000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	380468	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	9569800	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	9254	USD
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	127361	USD
CY2018Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	159727	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3512864	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10198677	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2682628	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9470431	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	234779	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	308612	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q3	us-gaap	Other Income OtherIncome	3881	USD
	us-gaap	Other Income OtherIncome	219498	USD
CY2018Q3	us-gaap	Other Income OtherIncome	3768686	USD
	us-gaap	Other Income OtherIncome	12296669	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70226	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105888	USD
CY2017Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2833098	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	6874780	USD
CY2018Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1867803	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	827823	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	840577	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2621445	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1178468	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4074895	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191338054	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188213958	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188200000	USD
CY2017Q3	us-gaap	Revenues Revenues	3546680	USD
	us-gaap	Revenues Revenues	12162861	USD
CY2018Q3	us-gaap	Revenues Revenues	3666780	USD
	us-gaap	Revenues Revenues	12361338	USD
CY2017Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2919504	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8436497	USD
CY2018Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2334340	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7039933	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	170093	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	414722	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5017389	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	8859725	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2036117	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1450237	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13949712	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13863953	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2036117	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1450237	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7365038	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7016789	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-012594-index-headers.html	Edgar Link	pending
0001628280-18-012594-index.html	Edgar Link	pending
0001628280-18-012594.txt	Edgar Link	pending
0001628280-18-012594-xbrl.zip	Edgar Link	pending
a10q9302018document.htm	Edgar Link	pending
a10q9302018ex311.htm	Edgar Link	pending
a10q9302018ex312.htm	Edgar Link	pending
a10q9302018ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20180930.xml	Edgar Link	completed
nuro-20180930.xsd	Edgar Link	pending
nuro-20180930_cal.xml	Edgar Link	unprocessable
nuro-20180930_def.xml	Edgar Link	unprocessable
nuro-20180930_lab.xml	Edgar Link	unprocessable
nuro-20180930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2018 Q4 Form 10-Q Financial Statement

#000162828018012594 Filed on October 17, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2018 Q4 Form 10-Q Financial Statement

#000162828018012594 Filed on October 17, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro